Modulation of Attention-Deficit/Hyperactivity Disorder Symptoms by Short- and Long-Acting Methylphenidate over the Course of a Day

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of child and adolescent psychopharmacology

• Publication date

  2012-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1089/cap.2010.0146PMID 22364402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CPT performance, motor activity, and continuous relations to ADHD symptom domains: A developmental study

  2010cited by this paper
• Sex Differences in Attentional Performance and Their Modulation by Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder

  2010cited by this paper
• Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants

  2009cited by this paper
• Differentiating between ADHD sub-types on CCPT measures of sustained attention and vigilance.

  2009cited by this paper
• Behavioral and Brain Functions

  2008cited by this paper
• A test of alcohol dose effects on multiple behavioral measures of impulsivity.

  2008influential reference
• [Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications].

  2008cited by this paper
• [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].

  2008cited by this paper
• Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)

  2008cited by this paper
• Age‐Related Differences in Daily Attention Patterns in Preschool, Kindergarten, First‐Grade, and Fifth‐Grade Pupils

  2007cited by this paper
• Inhibitory Mechanisms and the Control of Attention

  2007cited by this paper
• Attention-Deficit/Hyperactivity Disorder: A Neuropsychological Perspective Towards DSM-V

  2007cited by this paper
• A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.

  2006cited by this paper
• Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.

  2006cited by this paper
• Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

  2006cited by this paper
• The Influence of Risperidone on Attentional Functions in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Co-Morbid Disruptive Behavior Disorder

  2006cited by this paper
• Methylphenidate Blood Levels and Therapeutic Response in Children with Attention-Deficit Hyperactivity Disorder I. Effects of Different Dosing Regimens

  2006influential reference
• Assessing medication effects in the MTA study using neuropsychological outcomes.

  2006cited by this paper
• Effect of methylphenidate formulation on treatment patterns and use of emergency room services.

  2006cited by this paper
• [Reliability of attention and verbal memory tests with normal children and adolescents--clinical implications].

  2005cited by this paper
• The Influence of Sertraline on Attention and Verbal Memory in Children and Adolescents with Anxiety Disorders

  2005cited by this paper
• Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade.

  2005cited by this paper
• Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability.

  2005cited by this paper
• Clinical Evaluation of Subjective and Objective Changes in Motor Activity and Attention in Children with Attention-Deficit/Hyperactivity Disorder in a Double-Blind Methylphenidate Trial

  2005cited by this paper
• Reliabilität von Aufmerksamkeits- und verbalen Gedächtnistests bei gesunden Kindern und Jugendlichen - Implikationen für die klinische Praxis

  2005cited by this paper
• Comparative efficacy of once–a–day extended–release methylphenidate, two–times–daily immediate–release methylphenidate, and placebo in a laboratory school setting

  2004cited by this paper
• Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate

  2004cited by this paper
• Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Compliance with Stimulants for Attention-Deficit/Hyperactivity Disorder

  2003cited by this paper
• Langzeitwirksames Methylphenidat bei Kindern mit Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen

  2003cited by this paper
• ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.

  2003cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR)

  2001cited by this paper
• Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

  2001cited by this paper
• Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.

  2001cited by this paper
• Symptom profiles in children with ADHD: effects of comorbidity and gender.

  2001cited by this paper
• Time-of-day variations of indicators of attention: performance, physiologic parameters, and self-assessment of sleepiness.

  2000cited by this paper
• Effect of Methylphenidate on Attention in Children with Attention Deficit Hyperactivity Disorder (ADHD): ERP Evidence

  1999influential reference
• Human time production under constant routine

  1998cited by this paper
• Time of day variations in driving performance.

  1997cited by this paper
• Objective measurement of hyperactivity and attentional problems in ADHD.

  1996cited by this paper
• Circadian determinants of the postlunch dip in performance.

  1996cited by this paper
• Psychometric properties of impulsivity measures: temporal stability, validity and factor structure.

  1995cited by this paper
• Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children

  1995cited by this paper
• Continuous performance tests: a comparison of modalities.

  1995cited by this paper
• Actigraphy and Motion Analysis: New Tools for Psychiatry

  1995cited by this paper
• Locomotor activity in depressed children and adolescents: I. Circadian dysregulation.

  1993cited by this paper
• Children's motor activity: Reliability and relationship to attention and behavior

  1992cited by this paper
• Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder.

  1992cited by this paper
• Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms.

  1992cited by this paper
• A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls.

  1983cited by this paper

• Integrated Management of ADHD: A Multimodal Review of Pharmacological, Psychosocial, Digital, and Lifestyle Interventions

  2025cites this paper
• The Clinical Utility of the QbTest

  2025cites this paper
• Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD

  2024cites this paper
• The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study

  2021cites this paper
• Monitoring medication response in ADHD: what can continuous performance tests tell us?

  2021cites this paper
• School Entry Plays an Insignificant Role in Attention Performance, Impulse Control, and Motor Activity of Same-Aged Children from Preschool and Elementary School.

  2021cites this paper
• NDT_A_277490 19..32

  2021cites this paper
• Clinical Documentation for QbTest and QbCheck

  2020cites this paper
• The effects of practicing target-shooting sport on the severity of inattentive, hyperactive, and impulsive symptoms in children: a non-randomised controlled open-label study in Denmark

  2019cites this paper
• ADHD and the QbTest: Diagnostic Validity of QbTest

  2018cites this paper
• Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach

  2017cites this paper
• Clinical Documentation for QbTest in Patients With ADHD 1

  2017cites this paper
• Syddansk Universitet Does Test Dose of Central Stimulant Influence Continuous Performance Test ( CPT ) and Activity in Boys with Attention Deficit Hyperactivity Disorder ?

  2016influential citation
• University of Southern Denmark Does Test Dose of Central Stimulant Influence Continuous Performance Test (CPT) and Activity in Boys with Attention Deficit Hyperactivity Disorder?

  2016influential citation
• Effects of methylphenidate on appetite and growth in children diagnosed with attention deficit and hyperactivity disorder

  2016cites this paper
• The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review

  2016cites this paper
• Does Test Dose of Central Stimulant Influence Continuous Performance Test (CPT) and Activity in Boys with Attention Deficit Hyperactivity Disorder

  2016influential citation
• Is hyperactivity ubiquitous in ADHD or dependent on environmental demands? Evidence from meta-analysis.

  2016cites this paper
• Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD—‘Assessing QbTest Utility in ADHD’ (AQUA): a randomised controlled trial

  2014cites this paper
• Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

  2013cites this paper
• Global Assessment of Attention Deficit Hyperactivity Disorder : Examining objective Measures of Hyperactivity, Impulsivity and Inattention in Adults

  2012cites this paper
• Clinical Practice & Epidemiology in Mental Health

  year unknowncites this paper